ESMO 2024: Highlights and analysis
In the era of personalised medicine, one major goal behind the multidisciplinary structure and multi-professional format of the Congress is to accelerate and advance tailored cancer therapy and care. Central to the discussions in Stockholm will be the exploration of current challenges, differing perspectives, approaches and contra-opinions to help anticipate the future of personalised medicine in oncology. The panel also discusses the promise of emerging technologies such as novel radiation technologies and image guided cancer therapies which will be presented and debated throughout the newly introduced Onco-Technology Track.
ESMO 2024: Highlights and analysis
Addressing the rise of multiple myeloma in Rwanda
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
GIST tumours and soft tissue sarcomas
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Uncommon genetic aberrations NTRK, RET, NRG
War in Ukraine: The logistical challenges of transferring medical materials
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
Moving to the future: Artificial intelligence in surgery